{"gene":"TG_270250","gene_symbol":"GRA1","run_date":"2026-09-08T16:59:55+00:00","timeline":{"discoveries":[{"year":1997,"finding":"GRA1 is secreted from dense granules into the parasitophorous vacuole (PV) lumen as a soluble protein after host cell invasion, with secretion delayed until after the parasite is fully within the PV (peaking at ~20 min post-invasion), distinct from the earlier secretion of micronemal and rhoptry proteins.","method":"Immunofluorescence, immunoelectron microscopy, and quantitative immunoassays comparing kinetics of secretion from micronemes, rhoptries, and dense granules during host cell invasion","journal":"European journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (IFA, IEM, quantitative immunoassay) in a single rigorous study establishing sequential secretion kinetics","pmids":["9208224"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1989,"finding":"GRA1 (P23/P24) is a calcium-binding dense granule protein that is secreted into the host-cell-modified phagosome (parasitophorous vacuole) in both tachyzoite and bradyzoite forms; 45Ca2+ labeling and regional sequence homologies indicate Ca2+-binding properties.","method":"Immunocytochemical localization, 45Ca2+ radiolabeling, gene cloning and sequencing, heterologous expression in E. coli and eukaryotic cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization and 45Ca2+ labeling, single lab, multiple methods; Ca2+-binding inferred from labeling and homology, not reconstituted enzymatically","pmids":["2798425"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1995,"finding":"Following host-cell invasion, GRA1 is secreted from dense granules into the PV lumen as a soluble protein; it subsequently becomes peripherally associated with the intravacuolar tubulo-vesicular network (IVN). GRA1 is distinct from GRA2, which is delivered within multi-lamellar vesicles and becomes an integral membrane component of the IVN.","method":"Immunolabeling (IFA and immunoelectron microscopy) and cell fractionation of infected host cells","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal immunolabeling plus fractionation, replicated the secretion finding from a second independent study, established peripheral vs. integral membrane distinction","pmids":["7615684"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1996,"finding":"The GRA1 promoter contains critical cis-acting elements, specifically repeated motifs (A/TGAGACG) located between -129 and -47 relative to the transcription start site, that are required for optimal promoter activity; mutation of these motifs reduces CAT reporter expression.","method":"Transient transfection of T. gondii with CAT reporter gene constructs, promoter deletion analysis, quantitative CAT assay, mutation analysis","journal":"Molecular microbiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reporter assay with deletion and mutation analysis, single lab but multiple orthogonal constructs rigorously establishing cis-elements","pmids":["8858595"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1993,"finding":"GRA1 is localized to the matrix of dense granules in both tachyzoites and bradyzoites and is secreted into the parasitophorous vacuole and cyst ground substance. In bradyzoites, selective sorting of dense granule contents occurs: GRA2 is preferentially associated with the cyst wall ground substance and tubular network elements, GRA5 is on the delimiting membrane, while GRA1 distributes to the vacuolar/cyst matrix, indicating differential targeting of GRA proteins.","method":"Colloidal immunogold labeling with monoclonal antibodies, immunoelectron microscopy on tachyzoites and bradyzoites from distinct strains","journal":"Experimental parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — immunoelectron microscopy with multiple antibodies across life stages; single lab but orthogonal to other studies confirming soluble PV localization","pmids":["8344403"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1997,"finding":"Sporozoites contain GRA1 protein within cytoplasmic dense granules but do not exocytose GRA1 during formation of the first parasitophorous vacuole (PV1); GRA1 is retained intracellularly rather than being secreted into PV1, unlike in tachyzoite invasion.","method":"Immunolabeling of oocyst-derived sporozoites and infected host cells at defined time points post-infection, comparison with tachyzoite secretion","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct immunolabeling with stage-matched controls; single lab demonstrating stage-specific secretion difference","pmids":["9353039"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1999,"finding":"GRA1 protein is absent from the dense granules and parasitophorous vacuoles of merozoites and enteric (coccidian) stages in the cat small intestine, in contrast to its strong expression and secretion in tachyzoites and bradyzoites; this stage-specific absence is independent of NTPase expression.","method":"Immunolight and electron microscopy with antibodies against GRA1–6 and NTPase on cat intestinal sections containing merozoites, asexual and sexual stages","journal":"Experimental parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — immunoEM across multiple parasite stages in vivo; single lab, consistent with complementary in vivo study by Ferguson 2004","pmids":["10072322"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2008,"finding":"Within 10 min of invasion, GRA7 localizes to strand-like structures in the host cytosol that also contain GRA1 and GRA3, and GRA7 forms an association with rhoptry proteins ROP2 and ROP4 in infected host cells; this represents the first reported interaction between rhoptry-secreted and dense granule-secreted proteins.","method":"Immunofluorescence localization of GRA7 in infected host cells, co-localization with GRA1, GRA3, ROP2, and ROP4; phosphorylation analysis","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-localization by IFA (not co-IP); finding that GRA1 co-localizes in post-invasion strands is incidental to GRA7 study, single lab","pmids":["18809661"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2016,"finding":"Targeted knockout of the GRA1 locus in virulent type I RH strain could not be obtained, suggesting GRA1 may be essential for parasite viability, in contrast to GRA2–9 which were successfully knocked out.","method":"Targeted gene knockout attempts using homologous recombination in T. gondii RH strain; successful knockouts at GRA2–9 loci but not GRA1 or GRA10","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — negative result from gene targeting; inability to recover knockouts is suggestive but not definitive proof of essentiality; single lab","pmids":["27458822"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2019,"finding":"During tachyzoite-to-bradyzoite differentiation (in vitro cyst development), GRA1 relocalizes dynamically: by day 1 post-differentiation it is at the cyst periphery (colocalized with Dolichos biflorus agglutinin stain); by day 2, after GRA2 moves to the periphery, GRA1 establishes a continuous matrix pattern in the cyst interior; ultimately GRA1 is found predominantly in the inner layers of the cyst wall.","method":"Immunofluorescence localization of GRA1, GRA2, GRA4, GRA6, GRA9, GRA12 with cyst wall markers at multiple time points during in vitro differentiation; genetic deletion of individual GRA proteins to assess effects on cyst matrix and wall accumulation","journal":"mSphere","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization at multiple time points with stage-specific markers, plus genetic deletion epistasis for other GRAs; GRA1 localization is descriptive without GRA1 KO functional comparison (GRA1 KO not achievable)","pmids":["31619500"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2018,"finding":"Using GRA1 as bait in proximity-based biotinylation (BioID with GRA1-BirA* and APEX with GRA1-APEX), 46 proteins were identified in proximity to GRA1 in the parasitophorous vacuole, of which 20 were known GRA proteins; 5 of 26 novel proteins were validated as bona fide dense granule proteins by localization studies.","method":"Two proximity-based protein labeling approaches (BioID/BirA* and APEX) using GRA1 as bait, followed by streptavidin pulldown and mass spectrometry; localization validation by IFA","journal":"Journal of proteome research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal proximity labeling methods plus IFA validation; identifies GRA1-proximate proteins but does not establish direct binding","pmids":["30362762"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2011,"finding":"Recombinant GRA1 protein (but not MIC3) induces apoptosis of human monocytes via an autocrine TGF-β signaling mechanism: GRA1 stimulation activates TGF-β transcription and expression in monocytes, and selective inhibition of TGF-β type I receptors or neutralization of TGF-β reverses GRA1-induced apoptosis.","method":"Treatment of monocytes from patients with congenital toxoplasmosis and healthy donors with recombinant GRA1; apoptosis assays; TGF-β receptor inhibition; TGF-β neutralizing antibodies; RT-PCR for TGF-β and iNOS","journal":"Apoptosis : an international journal on programmed cell death","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional rescue experiments with receptor inhibitor and neutralizing antibody, single lab, multiple orthogonal approaches supporting autocrine TGF-β mechanism","pmids":["21390541"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2006,"finding":"Proteolysis of GRA1 is enhanced in MIC5 knockout parasites, indicating that MIC5 (or its downstream effector MPP2) influences proteolytic processing of GRA1 in addition to micronemal proteins; this phenotype is reversed by ALLN protease inhibitor treatment.","method":"MIC5 gene knockout by homologous recombination, Western blot analysis of GRA1 processing in knockout vs. wild-type and complemented parasites, protease inhibitor treatment","journal":"Eukaryotic cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with genetic complementation rescue, single lab; GRA1 proteolysis is a secondary finding in a MIC5 study","pmids":["16980407"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2020,"finding":"GRA1 (N-terminal region amino acids 41-152 of GRA6 was active, not GRA1) — specifically, recombinant GRA1 protein does NOT stimulate IFN-γ production by microglia in vitro, in contrast to the N-terminal region of GRA6.","method":"In vitro stimulation of microglia cell line and primary microglia with recombinant GRA1, GRA2, GRA5Nt, and GRA6 fragments; IFN-γ measurement by ELISA","journal":"Microbes and infection","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — negative result for GRA1 from a controlled in vitro assay; single lab, single method","pmids":["31972245"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2025,"finding":"GRA1 plays a critical role in maintaining the structural integrity of the intravacuolar network (IVN) within the parasitophorous vacuole. Conditional depletion of GRA1 causes: (1) growth arrest of tachyzoites; (2) metabolic defects (reduced glycolysis, TCA cycle activity, and cellular ATP); (3) disruption of mitochondrion and apicoplast integrity; (4) altered IVN membrane tubule structure; (5) impaired secretion of other GRA proteins (including GRA17) to the PV membrane and host cells; (6) severely reduced uptake of host nutrients (glucose, pantothenate); and (7) increased differentiation into bradyzoites.","method":"Conditional gene depletion (auxin-inducible degron or analogous system) of GRA1 in tachyzoites; metabolomics (glycolysis, TCA activity, ATP measurement); organelle morphology by microscopy; GRA protein localization by IFA; nutrient uptake assays; bradyzoite differentiation assays","journal":"mBio","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — conditional KO with multiple orthogonal functional readouts (metabolomics, organelle integrity, GRA mislocalization, nutrient uptake) in a single rigorous study establishing GRA1's mechanistic role in IVN integrity and nutrient scavenging","pmids":["40576341"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2010,"finding":"Expression of GRA1 targeted to the endoplasmic reticulum (ER) in macrophages (RAW264.7) promotes cell growth and adherence, and modulates arachidonic acid-stimulated intracellular calcium release kinetics (delay in Ca2+ peak from ~3 s to ~18 s), consistent with a Ca2+-buffering or regulatory role for GRA1 in the ER.","method":"Stable transfection of RAW264.7 macrophages with pCMV/myc/ER-GRA1; indirect immunofluorescence for ER localization; growth and adherence assays; confocal calcium imaging with Fluo-3 AM","journal":"Experimental parasitology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — heterologous expression system (macrophage cell line, not Toxoplasma), single lab, single study; mechanistic interpretation limited by non-native context","pmids":["20122928"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2025,"finding":"GRA1 protein is present in extracellular vesicles (EVs) isolated from Toxoplasma-infected primary neurons, along with GRA2, GRA7, MAG1, and MAG2; these parasite-containing EVs alter astrocyte gene expression, promoting pro-inflammatory transcriptional signatures and downregulating the glutamate transporter GLT-1.","method":"EV isolation from infected primary murine cortical neurons; LC-MS/MS proteomics; nanoparticle tracking analysis; TEM; Western blot; microRNA sequencing; incubation of EVs with primary astrocytes; gene expression analysis","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple orthogonal methods (proteomics, TEM, NTA, functional astrocyte assay) but GRA1's specific functional contribution to EV effects was not individually dissected; single lab","pmids":["40523037"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]}],"current_model":"GRA1 is a calcium-binding dense granule protein secreted as a soluble protein into the parasitophorous vacuole (PV) lumen after host cell invasion, where it peripherally associates with the intravacuolar network (IVN) membrane tubules; its primary mechanistic role is maintaining IVN structural integrity to support secretion of other GRA effectors to the PV membrane and host cell, thereby enabling efficient scavenging of host nutrients (glucose, pantothenate) essential for tachyzoite proliferation and metabolic homeostasis, with conditional depletion causing metabolic collapse, organelle disruption, GRA mislocalization, nutrient uptake failure, and growth arrest."},"narrative":{"mechanistic_narrative":"GRA1 is a calcium-binding dense granule protein of Toxoplasma gondii that is secreted into the parasitophorous vacuole (PV) as a key structural determinant of the intravacuolar network (IVN) and host-nutrient scavenging [PMID:2798425, PMID:40576341]. After host-cell invasion it is discharged from dense granules into the PV lumen as a soluble protein, with secretion delayed relative to micronemal and rhoptry proteins and peaking around 20 min post-invasion, and it subsequently associates peripherally with the tubulo-vesicular IVN — distinct from the integral IVN membrane protein GRA2 [PMID:9208224, PMID:7615684]. Its central mechanistic role is maintaining IVN structural integrity: conditional depletion in tachyzoites disrupts IVN membrane tubules, mislocalizes other GRA effectors (including GRA17) away from the PV membrane, collapses glucose and pantothenate uptake, impairs glycolytic and TCA metabolism and ATP levels, damages the mitochondrion and apicoplast, and arrests growth while driving bradyzoite differentiation [PMID:40576341]. GRA1 expression and trafficking are stage-specific — abundant in tachyzoites and bradyzoites but not exocytosed in sporozoites and absent from enteric merozoite stages — and during cyst formation it redistributes to establish a continuous matrix in the cyst interior and inner cyst wall [PMID:9353039, PMID:10072322, PMID:31619500]. Calcium binding was inferred from 45Ca2+ labeling and sequence features [PMID:2798425], and transcription depends on repeated A/TGAGACG cis-elements in the GRA1 promoter [PMID:8858595]. Beyond its intravacuolar function, recombinant GRA1 induces apoptosis of human monocytes through an autocrine TGF-β mechanism [PMID:21390541].","teleology":[{"year":1989,"claim":"Establishing GRA1's identity answered where this abundant antigen resides and what biochemical property it carries, defining it as a secreted calcium-binding dense granule protein.","evidence":"Immunocytochemistry, 45Ca2+ radiolabeling, and cloning/heterologous expression of GRA1 (P23/P24)","pmids":["2798425"],"confidence":"Medium","gaps":["Ca2+ binding inferred from labeling and homology, not enzymatically reconstituted","No defined EF-hand or structural basis for Ca2+ coordination","Functional consequence of Ca2+ binding in the PV not addressed"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1993,"claim":"Comparative immunogold localization resolved that GRA proteins are differentially sorted, placing GRA1 in the soluble vacuolar/cyst matrix rather than membranes or cyst wall.","evidence":"Colloidal immunogold immunoelectron microscopy of tachyzoites and bradyzoites","pmids":["8344403"],"confidence":"Medium","gaps":["Sorting mechanism directing GRA1 to matrix vs. membrane unknown","No functional test of matrix localization"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1995,"claim":"Reciprocal immunolabeling and fractionation distinguished GRA1's peripheral IVN association from GRA2's integral membrane insertion, defining how GRA1 engages the intravacuolar network.","evidence":"IFA, immunoEM, and cell fractionation of infected host cells comparing GRA1 and GRA2","pmids":["7615684"],"confidence":"High","gaps":["Molecular basis of GRA1 peripheral membrane association not defined","No demonstration of direct lipid or protein binding to IVN"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1996,"claim":"Promoter dissection identified the cis-elements driving GRA1 transcription, defining how its high-level expression is regulated.","evidence":"Transient CAT reporter transfection with promoter deletion and mutation analysis","pmids":["8858595"],"confidence":"High","gaps":["Trans-acting factors binding the A/TGAGACG motifs not identified","Link to stage-specific expression not established"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1997,"claim":"Secretion-kinetics and stage-comparison studies established that GRA1 discharge is temporally distinct (post-invasion) and stage-regulated, being retained in sporozoites rather than secreted into the first PV.","evidence":"Quantitative immunoassay/IFA/IEM of invasion kinetics; immunolabeling of sporozoite versus tachyzoite invasion","pmids":["9208224","9353039"],"confidence":"Medium","gaps":["Signal triggering delayed dense-granule secretion unknown","Mechanism of sporozoite-specific retention unresolved"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1999,"claim":"In vivo staining across enteric stages showed GRA1 is absent from merozoites and coccidian stages, refining the stage-specificity of its expression.","evidence":"Immunolight and electron microscopy of cat intestinal sections","pmids":["10072322"],"confidence":"Medium","gaps":["Basis of stage-specific transcriptional silencing not defined","Independence from NTPase not mechanistically explained"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2006,"claim":"Analysis of MIC5-knockout parasites revealed that GRA1 undergoes regulated proteolytic processing controlled by the MIC5/MPP2 axis, connecting dense-granule and micronemal protein maturation.","evidence":"MIC5 KO with genetic complementation, GRA1 Western blot, and ALLN protease inhibition","pmids":["16980407"],"confidence":"Medium","gaps":["Direct protease acting on GRA1 not identified","Functional consequence of GRA1 processing unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2008,"claim":"Co-localization studies placed GRA1 within early post-invasion host-cytosolic strands containing GRA3 and GRA7, hinting at coordination between dense-granule and rhoptry protein networks.","evidence":"IFA co-localization of GRA7 with GRA1, GRA3, ROP2, ROP4 in infected cells","pmids":["18809661"],"confidence":"Medium","gaps":["Co-localization by IFA only, no direct interaction shown for GRA1","Functional role of GRA1 in these strands not tested"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2011,"claim":"A host-directed assay showed recombinant GRA1 can drive human monocyte apoptosis via autocrine TGF-β signaling, indicating an immunomodulatory activity distinct from its intravacuolar structural role.","evidence":"Monocyte apoptosis assays with recombinant GRA1, TGF-β receptor inhibition, and neutralizing antibodies","pmids":["21390541"],"confidence":"Medium","gaps":["Physiological relevance of secreted native GRA1 in this pathway unclear","GRA1 receptor/target on monocytes not identified"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2016,"claim":"Systematic knockout attempts across the GRA1–9 loci found GRA1 refractory to deletion in the RH strain, implicating it as essential in contrast to the dispensable GRA2–9.","evidence":"Homologous-recombination gene targeting in T. gondii RH strain","pmids":["27458822"],"confidence":"Medium","gaps":["Negative result does not formally prove essentiality","No conditional system used to define the essential function here"],"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2018,"claim":"Proximity-labeling mapping used GRA1 as a bait to enumerate the PV proteome, defining its molecular neighborhood and identifying novel dense granule proteins.","evidence":"BioID (GRA1-BirA*) and APEX (GRA1-APEX) proximity labeling with mass spectrometry and IFA validation","pmids":["30362762"],"confidence":"Medium","gaps":["Proximity does not establish direct GRA1 binding","Which neighbors are functional partners not determined"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2019,"claim":"Time-resolved imaging during in vitro cyst formation showed GRA1 dynamically relocalizes to build a continuous cyst-interior matrix and inner cyst wall, extending its structural role into the bradyzoite stage.","evidence":"IFA of GRA1 with cyst-wall markers over differentiation time course; genetic deletion of other GRAs","pmids":["31619500"],"confidence":"Medium","gaps":["GRA1 KO not achievable, so its functional requirement for cyst matrix untested","Signals directing GRA1 relocalization unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2025,"claim":"Conditional depletion finally resolved GRA1's essential mechanism, showing it maintains IVN integrity required for GRA effector secretion, host-nutrient scavenging, metabolic homeostasis, and organelle integrity.","evidence":"Conditional degron depletion of GRA1 with metabolomics, organelle imaging, GRA localization, nutrient uptake, and differentiation assays","pmids":["40576341"],"confidence":"High","gaps":["Direct molecular basis of GRA1-IVN membrane interaction not defined","Whether metabolic defects are all downstream of IVN disruption vs. independent roles not separated"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2025,"claim":"Detection of GRA1 in infected-neuron extracellular vesicles that reprogram astrocytes raised the possibility of a GRA1 role in host CNS signaling beyond the PV.","evidence":"EV proteomics, TEM/NTA, and astrocyte gene-expression assays from infected primary neurons","pmids":["40523037"],"confidence":"Medium","gaps":["GRA1's individual contribution to EV-driven astrocyte effects not dissected","Mechanism of GRA1 loading into EVs unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":null,"claim":"The direct molecular basis of GRA1's peripheral association with IVN membranes and how its calcium-binding activity contributes to IVN integrity and nutrient scavenging remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of GRA1 or its membrane/Ca2+-binding interface","Whether Ca2+ binding is required for IVN function untested","Direct binding partners on the IVN not identified"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":[],"partners":["GRA2 (DISTINCT IVN ASSOCIATION; CO-LOCALIZED) [#2]","GRA3, GRA7 (POST-INVASION HOST-CYTOSOLIC STRANDS, CO-LOCALIZATION) [#7]","GRA17 AND OTHER GRA EFFECTORS (SECRETION DEPENDENT ON GRA1) [#14]","MIC5/MPP2 (REGULATES GRA1 PROTEOLYTIC PROCESSING) [#12]","46 PV PROTEINS IDENTIFIED BY GRA1 PROXIMITY LABELING, INCL. 20 KNOWN GRAS [#10]"],"other_free_text":["GRA1 transcription requires repeated A/TGAGACG cis-elements at -129 to -47 of its promoter [#3]","Stage-specific expression/secretion: secreted in tachyzoites and bradyzoites, retained intracellularly in sporozoites, absent from merozoites/enteric stages [#5, #6]","During cyst formation GRA1 relocalizes to the cyst-interior matrix and inner cyst wall [#9]","Deletion of GRA1 not achievable in RH strain, consistent with essentiality [#8]","Recombinant GRA1 does not stimulate IFN-γ production by microglia [#13]","ER-targeted GRA1 in macrophages delays arachidonic-acid-stimulated Ca2+ peaks, consistent with Ca2+-buffering (Low confidence, heterologous) [#15]"]},"strain_conflicts":[]},"prefetch_data":{},"corpus_meta":[{"pmid":"9208224","id":"PMC_9208224","title":"Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts.","date":"1997","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9208224","citation_count":565,"is_preprint":false},{"pmid":"2798425","id":"PMC_2798425","title":"Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2798425","citation_count":175,"is_preprint":false},{"pmid":"7615684","id":"PMC_7615684","title":"Regulated secretion of multi-lamellar vesicles leads to formation of a tubulo-vesicular network in host-cell vacuoles occupied by Toxoplasma gondii.","date":"1995","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/7615684","citation_count":170,"is_preprint":false},{"pmid":"10699010","id":"PMC_10699010","title":"Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay.","date":"2000","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10699010","citation_count":132,"is_preprint":false},{"pmid":"12455982","id":"PMC_12455982","title":"Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression.","date":"2002","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/12455982","citation_count":131,"is_preprint":false},{"pmid":"10603366","id":"PMC_10603366","title":"DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice.","date":"2000","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10603366","citation_count":129,"is_preprint":false},{"pmid":"15003495","id":"PMC_15003495","title":"Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host.","date":"2004","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/15003495","citation_count":118,"is_preprint":false},{"pmid":"15071048","id":"PMC_15071048","title":"Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis.","date":"2004","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/15071048","citation_count":98,"is_preprint":false},{"pmid":"14559390","id":"PMC_14559390","title":"Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies.","date":"2003","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/14559390","citation_count":83,"is_preprint":false},{"pmid":"8522178","id":"PMC_8522178","title":"Stable DNA transformation of Toxoplasma gondii using phleomycin selection.","date":"1995","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8522178","citation_count":82,"is_preprint":false},{"pmid":"18809661","id":"PMC_18809661","title":"The Toxoplasma gondii dense granule protein GRA7 is phosphorylated upon invasion and forms an unexpected association with the rhoptry proteins ROP2 and ROP4.","date":"2008","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18809661","citation_count":78,"is_preprint":false},{"pmid":"18221825","id":"PMC_18221825","title":"An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs.","date":"2007","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/18221825","citation_count":63,"is_preprint":false},{"pmid":"12496180","id":"PMC_12496180","title":"A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection.","date":"2003","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12496180","citation_count":60,"is_preprint":false},{"pmid":"17727568","id":"PMC_17727568","title":"GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.","date":"2007","source":"Parasite immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17727568","citation_count":58,"is_preprint":false},{"pmid":"21251760","id":"PMC_21251760","title":"Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii.","date":"2010","source":"Veterinary parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/21251760","citation_count":57,"is_preprint":false},{"pmid":"12633654","id":"PMC_12633654","title":"Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries.","date":"2003","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/12633654","citation_count":54,"is_preprint":false},{"pmid":"9353039","id":"PMC_9353039","title":"Toxoplasma gondii sporozoites form a transient parasitophorous vacuole that is impermeable and contains only a subset of dense-granule proteins.","date":"1997","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9353039","citation_count":51,"is_preprint":false},{"pmid":"14572515","id":"PMC_14572515","title":"Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma.","date":"2003","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/14572515","citation_count":50,"is_preprint":false},{"pmid":"16896649","id":"PMC_16896649","title":"Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis.","date":"2006","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/16896649","citation_count":49,"is_preprint":false},{"pmid":"11730793","id":"PMC_11730793","title":"Identification of a human immunodominant B-cell epitope within the GRA1 antigen of Toxoplasma gondii by phage display of cDNA libraries.","date":"2001","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/11730793","citation_count":48,"is_preprint":false},{"pmid":"10882660","id":"PMC_10882660","title":"Enzyme-linked immunosorbent assays using the recombinant dense granule antigens GRA6 and GRA1 of Toxoplasma gondii for detection of immunoglobulin G antibodies.","date":"2000","source":"Clinical and diagnostic laboratory immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10882660","citation_count":47,"is_preprint":false},{"pmid":"29844632","id":"PMC_29844632","title":"Bioinformatics analysis of single and multi-hybrid epitopes of GRA-1, GRA-4, GRA-6 and GRA-7 proteins to improve DNA vaccine design against Toxoplasma gondii.","date":"2018","source":"Journal of parasitic diseases : official organ of the Indian Society for Parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/29844632","citation_count":46,"is_preprint":false},{"pmid":"8858595","id":"PMC_8858595","title":"Common cis-acting elements critical for the expression of several genes of Toxoplasma gondii.","date":"1996","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/8858595","citation_count":46,"is_preprint":false},{"pmid":"10072322","id":"PMC_10072322","title":"The expression and distribution of dense granule proteins in the enteric (Coccidian) forms of Toxoplasma gondii in the small intestine of the cat.","date":"1999","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/10072322","citation_count":46,"is_preprint":false},{"pmid":"8344403","id":"PMC_8344403","title":"Toxoplasma gondii: differential location of antigens secreted from encysted bradyzoites.","date":"1993","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/8344403","citation_count":45,"is_preprint":false},{"pmid":"16707125","id":"PMC_16707125","title":"Toxoplasma gondii: an evaluation of diagnostic value of recombinant antigens in a murine model.","date":"2006","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/16707125","citation_count":44,"is_preprint":false},{"pmid":"12509997","id":"PMC_12509997","title":"High yield expression and single-step purification of Toxoplasma gondii SAG1, GRA1, and GRA7 antigens in Escherichia coli.","date":"2003","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/12509997","citation_count":42,"is_preprint":false},{"pmid":"21939715","id":"PMC_21939715","title":"Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B- and T-cell epitopes from T. gondii antigens.","date":"2011","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/21939715","citation_count":42,"is_preprint":false},{"pmid":"18207143","id":"PMC_18207143","title":"Toxoplasma gondii: enzyme-linked immunosorbent assay using different fragments of recombinant microneme protein 1 (MIC1) for detection of immunoglobulin G antibodies.","date":"2008","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/18207143","citation_count":40,"is_preprint":false},{"pmid":"22496494","id":"PMC_22496494","title":"Peptide microarray analysis of in silico-predicted epitopes for serological diagnosis of Toxoplasma gondii infection in humans.","date":"2012","source":"Clinical and vaccine immunology : CVI","url":"https://pubmed.ncbi.nlm.nih.gov/22496494","citation_count":40,"is_preprint":false},{"pmid":"19288132","id":"PMC_19288132","title":"Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice.","date":"2009","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/19288132","citation_count":39,"is_preprint":false},{"pmid":"31442457","id":"PMC_31442457","title":"A systematic review on the role of GRA proteins of Toxoplasma gondii in host immunization.","date":"2019","source":"Journal of microbiological methods","url":"https://pubmed.ncbi.nlm.nih.gov/31442457","citation_count":38,"is_preprint":false},{"pmid":"10067676","id":"PMC_10067676","title":"Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii.","date":"1999","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/10067676","citation_count":37,"is_preprint":false},{"pmid":"20117266","id":"PMC_20117266","title":"Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells.","date":"2010","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/20117266","citation_count":37,"is_preprint":false},{"pmid":"15539499","id":"PMC_15539499","title":"Limited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women.","date":"2004","source":"Clinical and diagnostic laboratory immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15539499","citation_count":35,"is_preprint":false},{"pmid":"27458822","id":"PMC_27458822","title":"Phenotypes Associated with Knockouts of Eight Dense Granule Gene Loci (GRA2-9) in Virulent Toxoplasma gondii.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27458822","citation_count":34,"is_preprint":false},{"pmid":"25268351","id":"PMC_25268351","title":"Diagnostic value of a Rec-ELISA using Toxoplasma gondii recombinant SporoSAG, BAG1, and GRA1 proteins in murine models infected orally with tissue cysts and oocysts.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25268351","citation_count":33,"is_preprint":false},{"pmid":"25817245","id":"PMC_25817245","title":"Serodiagnosis of Toxoplasma gondii infection in farm animals (horses, swine, and sheep) by enzyme-linked immunosorbent assay using chimeric antigens.","date":"2015","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/25817245","citation_count":33,"is_preprint":false},{"pmid":"24685150","id":"PMC_24685150","title":"Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice.","date":"2014","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/24685150","citation_count":33,"is_preprint":false},{"pmid":"22837100","id":"PMC_22837100","title":"Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice.","date":"2012","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/22837100","citation_count":32,"is_preprint":false},{"pmid":"9178265","id":"PMC_9178265","title":"Expression of Toxoplasma gondii genes in the closely-related apicomplexan parasite Neospora caninum.","date":"1997","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/9178265","citation_count":31,"is_preprint":false},{"pmid":"26055987","id":"PMC_26055987","title":"A new Toxoplasma gondii chimeric antigen containing fragments of SAG2, GRA1, and ROP1 proteins-impact of immunodominant sequences size on its diagnostic usefulness.","date":"2015","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/26055987","citation_count":30,"is_preprint":false},{"pmid":"31619500","id":"PMC_31619500","title":"Toxoplasma gondii Intravacuolar-Network-Associated Dense Granule Proteins Regulate Maturation of the Cyst Matrix and Cyst Wall.","date":"2019","source":"mSphere","url":"https://pubmed.ncbi.nlm.nih.gov/31619500","citation_count":29,"is_preprint":false},{"pmid":"24090568","id":"PMC_24090568","title":"Identification of novel B cell epitopes within Toxoplasma gondii GRA1.","date":"2013","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/24090568","citation_count":28,"is_preprint":false},{"pmid":"31170254","id":"PMC_31170254","title":"The first study on the usefulness of recombinant tetravalent chimeric proteins containing fragments of SAG2, GRA1, ROP1 and AMA1 antigens in the detection of specific anti-Toxoplasma gondii antibodies in mouse and human sera.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31170254","citation_count":27,"is_preprint":false},{"pmid":"25016474","id":"PMC_25016474","title":"Evaluation of recombinant granule antigens GRA1 and GRA7 for serodiagnosis of Toxoplasma gondii infection in dogs.","date":"2014","source":"BMC veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/25016474","citation_count":27,"is_preprint":false},{"pmid":"10503251","id":"PMC_10503251","title":"In vivo expression and distribution of dense granule protein 7 (GRA7) in the exoenteric (tachyzoite, bradyzoite) and enteric (coccidian) forms of Toxoplasma gondii.","date":"1999","source":"Parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/10503251","citation_count":26,"is_preprint":false},{"pmid":"30362762","id":"PMC_30362762","title":"Identification of Novel Dense-Granule Proteins in Toxoplasma gondii by Two Proximity-Based Biotinylation Approaches.","date":"2018","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/30362762","citation_count":25,"is_preprint":false},{"pmid":"23683335","id":"PMC_23683335","title":"Seroprevalence of toxoplasmosis, toxocariasis and cysticercosis in a rural settlement, São Paulo State, Brazil.","date":"2013","source":"Pathogens and global health","url":"https://pubmed.ncbi.nlm.nih.gov/23683335","citation_count":25,"is_preprint":false},{"pmid":"18006371","id":"PMC_18006371","title":"Construction of Toxoplasma gondii bradyzoite expressing the green fluorescent protein.","date":"2007","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/18006371","citation_count":23,"is_preprint":false},{"pmid":"16980407","id":"PMC_16980407","title":"Targeted deletion of MIC5 enhances trimming proteolysis of Toxoplasma invasion proteins.","date":"2006","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/16980407","citation_count":22,"is_preprint":false},{"pmid":"25975627","id":"PMC_25975627","title":"Evaluation of an indirect ELISA using recombinant granule antigen GRA1, GRA7 and soluble antigens for serodiagnosis of Toxoplasma gondii infection in chickens.","date":"2015","source":"Research in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/25975627","citation_count":21,"is_preprint":false},{"pmid":"21414723","id":"PMC_21414723","title":"IFN-γ expression and infectivity of Toxoplasma infected tissues are associated with an antibody response against GRA7 in experimentally infected pigs.","date":"2011","source":"Veterinary parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/21414723","citation_count":21,"is_preprint":false},{"pmid":"25300561","id":"PMC_25300561","title":"The optimal mixture of Toxoplasma gondii recombinant antigens (GRA1, P22, ROP1) for diagnosis of ovine toxoplasmosis.","date":"2014","source":"Veterinary parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/25300561","citation_count":20,"is_preprint":false},{"pmid":"11511000","id":"PMC_11511000","title":"Towards the Toxoplasma gondii proteome: position of 13 parasite excretory antigens on a standardized map of two-dimensionally separated tachyzoite proteins.","date":"2001","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/11511000","citation_count":20,"is_preprint":false},{"pmid":"27059254","id":"PMC_27059254","title":"Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice.","date":"2016","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/27059254","citation_count":17,"is_preprint":false},{"pmid":"29398460","id":"PMC_29398460","title":"A novel chemiluminescent immunoassay based on original acridinium ester labels as better solution for diagnosis of human toxoplasmosis than conventional ELISA test.","date":"2018","source":"Diagnostic microbiology and infectious disease","url":"https://pubmed.ncbi.nlm.nih.gov/29398460","citation_count":17,"is_preprint":false},{"pmid":"17223600","id":"PMC_17223600","title":"Age-dependent impairment of functional helper T cell responses to immunodominant epitopes of Toxoplasma gondii antigens in congenitally infected individuals.","date":"2006","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/17223600","citation_count":17,"is_preprint":false},{"pmid":"20464125","id":"PMC_20464125","title":"High diagnostic efficiency of IgM-ELISA with the use of multiple antigen peptides (MAP1) from T. gondii ESA (SAG-1, GRA-1 and GRA-7), in acute toxoplasmosis.","date":"2010","source":"Revista do Instituto de Medicina Tropical de Sao Paulo","url":"https://pubmed.ncbi.nlm.nih.gov/20464125","citation_count":17,"is_preprint":false},{"pmid":"25499128","id":"PMC_25499128","title":"Interferon-gamma expression and infectivity of Toxoplasma infected tissues in experimentally infected sheep in comparison with pigs.","date":"2014","source":"Veterinary parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/25499128","citation_count":16,"is_preprint":false},{"pmid":"17825290","id":"PMC_17825290","title":"Toxoplasma gondii: chimeric Dr fimbriae as a recombinant vaccine against toxoplasmosis.","date":"2007","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/17825290","citation_count":14,"is_preprint":false},{"pmid":"21390541","id":"PMC_21390541","title":"Toxoplasma gondii Dense Granule Antigen 1 stimulates apoptosis of monocytes through autocrine TGF-β signaling.","date":"2011","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/21390541","citation_count":13,"is_preprint":false},{"pmid":"31704144","id":"PMC_31704144","title":"Prevalence of Toxoplasma gondii parasite in captive Mexican jaguars determined by recombinant surface antigens (SAG1) and dense granular antigens (GRA1 and GRA7) in ELISA-based serodiagnosis.","date":"2019","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/31704144","citation_count":12,"is_preprint":false},{"pmid":"20122928","id":"PMC_20122928","title":"Toxoplasma gondii: expression of GRA1 gene in endoplasmic reticulum promotes both growth and adherence and modulates intracellular calcium release in macrophages.","date":"2010","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/20122928","citation_count":12,"is_preprint":false},{"pmid":"26199291","id":"PMC_26199291","title":"A comparative study of Toxoplasma gondii seroprevalence in mink using a modified agglutination test, a Western blot, and enzyme-linked immunosorbent assays.","date":"2015","source":"Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/26199291","citation_count":12,"is_preprint":false},{"pmid":"23965849","id":"PMC_23965849","title":"Establishment and application of a loop-mediated isothermal amplification method for simple, specific, sensitive and rapid detection of Toxoplasma gondii.","date":"2013","source":"The Journal of veterinary medical science","url":"https://pubmed.ncbi.nlm.nih.gov/23965849","citation_count":11,"is_preprint":false},{"pmid":"31847285","id":"PMC_31847285","title":"Toxoplasma gondii Tetravalent Chimeric Proteins as Novel Antigens for Detection of Specific Immunoglobulin G in Sera of Small Ruminants.","date":"2019","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/31847285","citation_count":11,"is_preprint":false},{"pmid":"33651824","id":"PMC_33651824","title":"Detection of toxoplasmic encephalitis in HIV positive patients in urine with hydrogel nanoparticles.","date":"2021","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/33651824","citation_count":10,"is_preprint":false},{"pmid":"29969590","id":"PMC_29969590","title":"Analysis of Toxoplasma gondii clonal type-specific antibody reactions in experimentally infected turkeys and chickens.","date":"2018","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/29969590","citation_count":10,"is_preprint":false},{"pmid":"33242641","id":"PMC_33242641","title":"Engineering an efficient poly-epitope vaccine against Toxoplasma gondii infection: A computational vaccinology study.","date":"2020","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/33242641","citation_count":10,"is_preprint":false},{"pmid":"27298047","id":"PMC_27298047","title":"A novel chemiluminescent immunoassay for detection of Toxoplasma gondii IgG in human sera.","date":"2016","source":"Diagnostic microbiology and infectious disease","url":"https://pubmed.ncbi.nlm.nih.gov/27298047","citation_count":10,"is_preprint":false},{"pmid":"37563166","id":"PMC_37563166","title":"Evaluation of long-term immunity and protection against T. gondii after immunization with multivalent recombinant chimeric T. gondii proteins.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37563166","citation_count":9,"is_preprint":false},{"pmid":"31635267","id":"PMC_31635267","title":"The Impact of the Antigenic Composition of Chimeric Proteins on Their Immunoprotective Activity against Chronic Toxoplasmosis in Mice.","date":"2019","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/31635267","citation_count":9,"is_preprint":false},{"pmid":"35681854","id":"PMC_35681854","title":"Toxoplasma gondii and Neospora caninum Infections in Stray Cats and Dogs in the Qinghai-Tibetan Plateau Area, China.","date":"2022","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/35681854","citation_count":9,"is_preprint":false},{"pmid":"38576040","id":"PMC_38576040","title":"Trx4, a novel thioredoxin protein, is important for Toxoplasma gondii fitness.","date":"2024","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/38576040","citation_count":8,"is_preprint":false},{"pmid":"38673969","id":"PMC_38673969","title":"The Development of Toxoplasma gondii Recombinant Trivalent Chimeric Proteins as an Alternative to Toxoplasma Lysate Antigen (TLA) in Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Immunoglobulin G (IgG) in Small Ruminants.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38673969","citation_count":8,"is_preprint":false},{"pmid":"15860934","id":"PMC_15860934","title":"Toxoplasma gondii antigens GRA1 (p24) and SAG1 (p30): a comparison of their stimulatory influence on T-cell activation and cytokine expression in in vitro cultures.","date":"2005","source":"Pathobiology : journal of immunopathology, molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15860934","citation_count":6,"is_preprint":false},{"pmid":"34404476","id":"PMC_34404476","title":"Characterization and evaluation of a recombinant multiepitope peptide antigen MAG in the serological diagnosis of Toxoplasma gondii infection in pigs.","date":"2021","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/34404476","citation_count":6,"is_preprint":false},{"pmid":"33276579","id":"PMC_33276579","title":"The Immunogenic and Immunoprotective Activities of Recombinant Chimeric T. gondii Proteins Containing AMA1 Antigen Fragments.","date":"2020","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/33276579","citation_count":6,"is_preprint":false},{"pmid":"29203146","id":"PMC_29203146","title":"Toward detection of toxoplasmosis from urine in mice using hydro-gel nanoparticles concentration and parallel reaction monitoring mass spectrometry.","date":"2017","source":"Nanomedicine : nanotechnology, biology, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29203146","citation_count":6,"is_preprint":false},{"pmid":"41865077","id":"PMC_41865077","title":"Development and validation of a gra1-bag1 RT-qPCR assay as an alternative to the mouse bioassay for assessing Toxoplasma gondii viability.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41865077","citation_count":0,"is_preprint":false},{"pmid":"42347666","id":"PMC_42347666","title":"Immunogenicity of a Recombinant Multi-Epitope Vaccine Incorporating GRA14, SAG1, and GRA1 Antigens of Toxoplasma gondii in BALB/c Mice.","date":"2026","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/42347666","citation_count":0,"is_preprint":false},{"pmid":"42075701","id":"PMC_42075701","title":"Seroprevalence of IgG Antibodies Against Toxoplasma gondii in HIV-Infected and Non-Infected Population in Iquitos, Peru.","date":"2026","source":"Pathogens (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/42075701","citation_count":0,"is_preprint":false},{"pmid":"41624283","id":"PMC_41624283","title":"Establishment of an ELISA for detecting oocyst-derived Toxoplasma gondii infections in sheep.","date":"2026","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/41624283","citation_count":0,"is_preprint":false},{"pmid":"40546389","id":"PMC_40546389","title":"Design and immunological evaluation of a multi-epitope vaccine candidate against Toxoplasma gondii incorporating MIC13, GRA1, and SAG1 antigens in BALB/c mice.","date":"2025","source":"Food and waterborne parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/40546389","citation_count":4,"is_preprint":false},{"pmid":"40576341","id":"PMC_40576341","title":"The critical role of Toxoplasma gondii GRA1 in nutrient salvage.","date":"2025","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/40576341","citation_count":3,"is_preprint":false},{"pmid":"40523037","id":"PMC_40523037","title":"Toxoplasma gondii infection of neurons alters the production and content of extracellular vesicles directing astrocyte phenotype and contributing to the loss of GLT-1 in the infected brain.","date":"2025","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/40523037","citation_count":3,"is_preprint":false},{"pmid":"40429830","id":"PMC_40429830","title":"A Structural In Silico Analysis of Novel Epitopes from Toxoplasma gondii Proteins for the Serodiagnosis of Toxoplasmosis.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40429830","citation_count":2,"is_preprint":false},{"pmid":"41412557","id":"PMC_41412557","title":"In vitro expression and seroreactivity of Toxoplasma gondii GRA1 protein encoded by unmodified and nucleoside-modified mRNA constructs.","date":"2025","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/41412557","citation_count":1,"is_preprint":false},{"pmid":"41398086","id":"PMC_41398086","title":"Prevalence of porcine toxoplasmosis using ERP-iELISA in Hubei Province.","date":"2025","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/41398086","citation_count":0,"is_preprint":false},{"pmid":"38958491","id":"PMC_38958491","title":"Molecular Models of Toxoplasma gondii in Humans and Animals.","date":"2024","source":"Turkiye parazitolojii dergisi","url":"https://pubmed.ncbi.nlm.nih.gov/38958491","citation_count":4,"is_preprint":false},{"pmid":"37886246","id":"PMC_37886246","title":"In Silico Vaccine Design and Expression of the Multi-Component Protein Candidate against the Toxoplasma gondii Parasite from MIC13, GRA1, and SAG1 Antigens.","date":"2023","source":"Iranian journal of parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/37886246","citation_count":5,"is_preprint":false},{"pmid":"39492179","id":"PMC_39492179","title":"An In house ELISA using recombinant GRA1 and BAG1 proteins as antigen successfully detected Toxoplasma gondii infection in a flock of sheep suffering from abortions.","date":"2023","source":"Research in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/39492179","citation_count":4,"is_preprint":false},{"pmid":"37868957","id":"PMC_37868957","title":"Dense granule protein 3 of Toxoplasma gondii plays a crucial role in the capability of the tissue cysts of the parasite to persist in the presence of anti-cyst CD8+ T cells during the chronic stage of infection.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37868957","citation_count":4,"is_preprint":false},{"pmid":"37647822","id":"PMC_37647822","title":"A preliminary study to develop a lateral flow assay using recombinant GRA1 protein for the diagnosis of toxoplasmosis in stray cats.","date":"2023","source":"Comparative immunology, microbiology and infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37647822","citation_count":2,"is_preprint":false},{"pmid":"31972245","id":"PMC_31972245","title":"The amino-terminal region of dense granule protein 6 of Toxoplasma gondii stimulates IFN-γ production by microglia.","date":"2020","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/31972245","citation_count":4,"is_preprint":false},{"pmid":"31970471","id":"PMC_31970471","title":"The effect of edelfosine on GRA1 and MIC3 expressions in acute toxoplasmosis.","date":"2020","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/31970471","citation_count":0,"is_preprint":false},{"pmid":"28591403","id":"PMC_28591403","title":"Preliminary multiplex microarray IgG immunoassay for the diagnosis of toxoplasmosis and rubella.","date":"2017","source":"Memorias do Instituto Oswaldo Cruz","url":"https://pubmed.ncbi.nlm.nih.gov/28591403","citation_count":5,"is_preprint":false},{"pmid":"22455755","id":"PMC_22455755","title":"Optimized expression of dual reporter genes in transient transfection of purified Toxoplasma gondii using different promoters.","date":"2012","source":"Canadian journal of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/22455755","citation_count":0,"is_preprint":false},{"pmid":"19424723","id":"PMC_19424723","title":"Expression of the tandem enhanced yellow fluorescent marker gene in Toxoplasma gondii.","date":"2009","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/19424723","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51254,"output_tokens":5017,"usd":0.114508,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11772,"output_tokens":5516,"usd":0.09838,"stage2_stop_reason":"end_turn"},"total_usd":0.0,"stage1_batch_id":"msgbatch_01XFXJD6iZecXyWn9uU5Qom9","stage2_batch_id":"msgbatch_013GToKgs4AKSCRE4yvueviH","note":"batch pricing = 50% of standard","skipped":true},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"GRA1 is secreted from dense granules into the parasitophorous vacuole (PV) lumen as a soluble protein after host cell invasion, with secretion delayed until after the parasite is fully within the PV (peaking at ~20 min post-invasion), distinct from the earlier secretion of micronemal and rhoptry proteins.\",\n      \"method\": \"Immunofluorescence, immunoelectron microscopy, and quantitative immunoassays comparing kinetics of secretion from micronemes, rhoptries, and dense granules during host cell invasion\",\n      \"journal\": \"European journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (IFA, IEM, quantitative immunoassay) in a single rigorous study establishing sequential secretion kinetics\",\n      \"pmids\": [\"9208224\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"GRA1 (P23/P24) is a calcium-binding dense granule protein that is secreted into the host-cell-modified phagosome (parasitophorous vacuole) in both tachyzoite and bradyzoite forms; 45Ca2+ labeling and regional sequence homologies indicate Ca2+-binding properties.\",\n      \"method\": \"Immunocytochemical localization, 45Ca2+ radiolabeling, gene cloning and sequencing, heterologous expression in E. coli and eukaryotic cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization and 45Ca2+ labeling, single lab, multiple methods; Ca2+-binding inferred from labeling and homology, not reconstituted enzymatically\",\n      \"pmids\": [\"2798425\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Following host-cell invasion, GRA1 is secreted from dense granules into the PV lumen as a soluble protein; it subsequently becomes peripherally associated with the intravacuolar tubulo-vesicular network (IVN). GRA1 is distinct from GRA2, which is delivered within multi-lamellar vesicles and becomes an integral membrane component of the IVN.\",\n      \"method\": \"Immunolabeling (IFA and immunoelectron microscopy) and cell fractionation of infected host cells\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal immunolabeling plus fractionation, replicated the secretion finding from a second independent study, established peripheral vs. integral membrane distinction\",\n      \"pmids\": [\"7615684\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The GRA1 promoter contains critical cis-acting elements, specifically repeated motifs (A/TGAGACG) located between -129 and -47 relative to the transcription start site, that are required for optimal promoter activity; mutation of these motifs reduces CAT reporter expression.\",\n      \"method\": \"Transient transfection of T. gondii with CAT reporter gene constructs, promoter deletion analysis, quantitative CAT assay, mutation analysis\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reporter assay with deletion and mutation analysis, single lab but multiple orthogonal constructs rigorously establishing cis-elements\",\n      \"pmids\": [\"8858595\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"GRA1 is localized to the matrix of dense granules in both tachyzoites and bradyzoites and is secreted into the parasitophorous vacuole and cyst ground substance. In bradyzoites, selective sorting of dense granule contents occurs: GRA2 is preferentially associated with the cyst wall ground substance and tubular network elements, GRA5 is on the delimiting membrane, while GRA1 distributes to the vacuolar/cyst matrix, indicating differential targeting of GRA proteins.\",\n      \"method\": \"Colloidal immunogold labeling with monoclonal antibodies, immunoelectron microscopy on tachyzoites and bradyzoites from distinct strains\",\n      \"journal\": \"Experimental parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — immunoelectron microscopy with multiple antibodies across life stages; single lab but orthogonal to other studies confirming soluble PV localization\",\n      \"pmids\": [\"8344403\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Sporozoites contain GRA1 protein within cytoplasmic dense granules but do not exocytose GRA1 during formation of the first parasitophorous vacuole (PV1); GRA1 is retained intracellularly rather than being secreted into PV1, unlike in tachyzoite invasion.\",\n      \"method\": \"Immunolabeling of oocyst-derived sporozoites and infected host cells at defined time points post-infection, comparison with tachyzoite secretion\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct immunolabeling with stage-matched controls; single lab demonstrating stage-specific secretion difference\",\n      \"pmids\": [\"9353039\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GRA1 protein is absent from the dense granules and parasitophorous vacuoles of merozoites and enteric (coccidian) stages in the cat small intestine, in contrast to its strong expression and secretion in tachyzoites and bradyzoites; this stage-specific absence is independent of NTPase expression.\",\n      \"method\": \"Immunolight and electron microscopy with antibodies against GRA1–6 and NTPase on cat intestinal sections containing merozoites, asexual and sexual stages\",\n      \"journal\": \"Experimental parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — immunoEM across multiple parasite stages in vivo; single lab, consistent with complementary in vivo study by Ferguson 2004\",\n      \"pmids\": [\"10072322\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Within 10 min of invasion, GRA7 localizes to strand-like structures in the host cytosol that also contain GRA1 and GRA3, and GRA7 forms an association with rhoptry proteins ROP2 and ROP4 in infected host cells; this represents the first reported interaction between rhoptry-secreted and dense granule-secreted proteins.\",\n      \"method\": \"Immunofluorescence localization of GRA7 in infected host cells, co-localization with GRA1, GRA3, ROP2, and ROP4; phosphorylation analysis\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-localization by IFA (not co-IP); finding that GRA1 co-localizes in post-invasion strands is incidental to GRA7 study, single lab\",\n      \"pmids\": [\"18809661\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Targeted knockout of the GRA1 locus in virulent type I RH strain could not be obtained, suggesting GRA1 may be essential for parasite viability, in contrast to GRA2–9 which were successfully knocked out.\",\n      \"method\": \"Targeted gene knockout attempts using homologous recombination in T. gondii RH strain; successful knockouts at GRA2–9 loci but not GRA1 or GRA10\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — negative result from gene targeting; inability to recover knockouts is suggestive but not definitive proof of essentiality; single lab\",\n      \"pmids\": [\"27458822\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"During tachyzoite-to-bradyzoite differentiation (in vitro cyst development), GRA1 relocalizes dynamically: by day 1 post-differentiation it is at the cyst periphery (colocalized with Dolichos biflorus agglutinin stain); by day 2, after GRA2 moves to the periphery, GRA1 establishes a continuous matrix pattern in the cyst interior; ultimately GRA1 is found predominantly in the inner layers of the cyst wall.\",\n      \"method\": \"Immunofluorescence localization of GRA1, GRA2, GRA4, GRA6, GRA9, GRA12 with cyst wall markers at multiple time points during in vitro differentiation; genetic deletion of individual GRA proteins to assess effects on cyst matrix and wall accumulation\",\n      \"journal\": \"mSphere\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization at multiple time points with stage-specific markers, plus genetic deletion epistasis for other GRAs; GRA1 localization is descriptive without GRA1 KO functional comparison (GRA1 KO not achievable)\",\n      \"pmids\": [\"31619500\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Using GRA1 as bait in proximity-based biotinylation (BioID with GRA1-BirA* and APEX with GRA1-APEX), 46 proteins were identified in proximity to GRA1 in the parasitophorous vacuole, of which 20 were known GRA proteins; 5 of 26 novel proteins were validated as bona fide dense granule proteins by localization studies.\",\n      \"method\": \"Two proximity-based protein labeling approaches (BioID/BirA* and APEX) using GRA1 as bait, followed by streptavidin pulldown and mass spectrometry; localization validation by IFA\",\n      \"journal\": \"Journal of proteome research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal proximity labeling methods plus IFA validation; identifies GRA1-proximate proteins but does not establish direct binding\",\n      \"pmids\": [\"30362762\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Recombinant GRA1 protein (but not MIC3) induces apoptosis of human monocytes via an autocrine TGF-β signaling mechanism: GRA1 stimulation activates TGF-β transcription and expression in monocytes, and selective inhibition of TGF-β type I receptors or neutralization of TGF-β reverses GRA1-induced apoptosis.\",\n      \"method\": \"Treatment of monocytes from patients with congenital toxoplasmosis and healthy donors with recombinant GRA1; apoptosis assays; TGF-β receptor inhibition; TGF-β neutralizing antibodies; RT-PCR for TGF-β and iNOS\",\n      \"journal\": \"Apoptosis : an international journal on programmed cell death\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional rescue experiments with receptor inhibitor and neutralizing antibody, single lab, multiple orthogonal approaches supporting autocrine TGF-β mechanism\",\n      \"pmids\": [\"21390541\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Proteolysis of GRA1 is enhanced in MIC5 knockout parasites, indicating that MIC5 (or its downstream effector MPP2) influences proteolytic processing of GRA1 in addition to micronemal proteins; this phenotype is reversed by ALLN protease inhibitor treatment.\",\n      \"method\": \"MIC5 gene knockout by homologous recombination, Western blot analysis of GRA1 processing in knockout vs. wild-type and complemented parasites, protease inhibitor treatment\",\n      \"journal\": \"Eukaryotic cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with genetic complementation rescue, single lab; GRA1 proteolysis is a secondary finding in a MIC5 study\",\n      \"pmids\": [\"16980407\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRA1 (N-terminal region amino acids 41-152 of GRA6 was active, not GRA1) — specifically, recombinant GRA1 protein does NOT stimulate IFN-γ production by microglia in vitro, in contrast to the N-terminal region of GRA6.\",\n      \"method\": \"In vitro stimulation of microglia cell line and primary microglia with recombinant GRA1, GRA2, GRA5Nt, and GRA6 fragments; IFN-γ measurement by ELISA\",\n      \"journal\": \"Microbes and infection\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — negative result for GRA1 from a controlled in vitro assay; single lab, single method\",\n      \"pmids\": [\"31972245\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GRA1 plays a critical role in maintaining the structural integrity of the intravacuolar network (IVN) within the parasitophorous vacuole. Conditional depletion of GRA1 causes: (1) growth arrest of tachyzoites; (2) metabolic defects (reduced glycolysis, TCA cycle activity, and cellular ATP); (3) disruption of mitochondrion and apicoplast integrity; (4) altered IVN membrane tubule structure; (5) impaired secretion of other GRA proteins (including GRA17) to the PV membrane and host cells; (6) severely reduced uptake of host nutrients (glucose, pantothenate); and (7) increased differentiation into bradyzoites.\",\n      \"method\": \"Conditional gene depletion (auxin-inducible degron or analogous system) of GRA1 in tachyzoites; metabolomics (glycolysis, TCA activity, ATP measurement); organelle morphology by microscopy; GRA protein localization by IFA; nutrient uptake assays; bradyzoite differentiation assays\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — conditional KO with multiple orthogonal functional readouts (metabolomics, organelle integrity, GRA mislocalization, nutrient uptake) in a single rigorous study establishing GRA1's mechanistic role in IVN integrity and nutrient scavenging\",\n      \"pmids\": [\"40576341\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Expression of GRA1 targeted to the endoplasmic reticulum (ER) in macrophages (RAW264.7) promotes cell growth and adherence, and modulates arachidonic acid-stimulated intracellular calcium release kinetics (delay in Ca2+ peak from ~3 s to ~18 s), consistent with a Ca2+-buffering or regulatory role for GRA1 in the ER.\",\n      \"method\": \"Stable transfection of RAW264.7 macrophages with pCMV/myc/ER-GRA1; indirect immunofluorescence for ER localization; growth and adherence assays; confocal calcium imaging with Fluo-3 AM\",\n      \"journal\": \"Experimental parasitology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — heterologous expression system (macrophage cell line, not Toxoplasma), single lab, single study; mechanistic interpretation limited by non-native context\",\n      \"pmids\": [\"20122928\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GRA1 protein is present in extracellular vesicles (EVs) isolated from Toxoplasma-infected primary neurons, along with GRA2, GRA7, MAG1, and MAG2; these parasite-containing EVs alter astrocyte gene expression, promoting pro-inflammatory transcriptional signatures and downregulating the glutamate transporter GLT-1.\",\n      \"method\": \"EV isolation from infected primary murine cortical neurons; LC-MS/MS proteomics; nanoparticle tracking analysis; TEM; Western blot; microRNA sequencing; incubation of EVs with primary astrocytes; gene expression analysis\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple orthogonal methods (proteomics, TEM, NTA, functional astrocyte assay) but GRA1's specific functional contribution to EV effects was not individually dissected; single lab\",\n      \"pmids\": [\"40523037\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"GRA1 is a calcium-binding dense granule protein secreted as a soluble protein into the parasitophorous vacuole (PV) lumen after host cell invasion, where it peripherally associates with the intravacuolar network (IVN) membrane tubules; its primary mechanistic role is maintaining IVN structural integrity to support secretion of other GRA effectors to the PV membrane and host cell, thereby enabling efficient scavenging of host nutrients (glucose, pantothenate) essential for tachyzoite proliferation and metabolic homeostasis, with conditional depletion causing metabolic collapse, organelle disruption, GRA mislocalization, nutrient uptake failure, and growth arrest.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GRA1 is a calcium-binding dense granule protein of Toxoplasma gondii that is secreted into the parasitophorous vacuole (PV) as a key structural determinant of the intravacuolar network (IVN) and host-nutrient scavenging [#1, #14]. After host-cell invasion it is discharged from dense granules into the PV lumen as a soluble protein, with secretion delayed relative to micronemal and rhoptry proteins and peaking around 20 min post-invasion, and it subsequently associates peripherally with the tubulo-vesicular IVN — distinct from the integral IVN membrane protein GRA2 [#0, #2]. Its central mechanistic role is maintaining IVN structural integrity: conditional depletion in tachyzoites disrupts IVN membrane tubules, mislocalizes other GRA effectors (including GRA17) away from the PV membrane, collapses glucose and pantothenate uptake, impairs glycolytic and TCA metabolism and ATP levels, damages the mitochondrion and apicoplast, and arrests growth while driving bradyzoite differentiation [#14]. GRA1 expression and trafficking are stage-specific — abundant in tachyzoites and bradyzoites but not exocytosed in sporozoites and absent from enteric merozoite stages — and during cyst formation it redistributes to establish a continuous matrix in the cyst interior and inner cyst wall [#5, #6, #9]. Calcium binding was inferred from 45Ca2+ labeling and sequence features [#1], and transcription depends on repeated A/TGAGACG cis-elements in the GRA1 promoter [#3]. Beyond its intravacuolar function, recombinant GRA1 induces apoptosis of human monocytes through an autocrine TGF-\\u03b2 mechanism [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Establishing GRA1's identity answered where this abundant antigen resides and what biochemical property it carries, defining it as a secreted calcium-binding dense granule protein.\",\n      \"evidence\": \"Immunocytochemistry, 45Ca2+ radiolabeling, and cloning/heterologous expression of GRA1 (P23/P24)\",\n      \"pmids\": [\"2798425\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ca2+ binding inferred from labeling and homology, not enzymatically reconstituted\", \"No defined EF-hand or structural basis for Ca2+ coordination\", \"Functional consequence of Ca2+ binding in the PV not addressed\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Comparative immunogold localization resolved that GRA proteins are differentially sorted, placing GRA1 in the soluble vacuolar/cyst matrix rather than membranes or cyst wall.\",\n      \"evidence\": \"Colloidal immunogold immunoelectron microscopy of tachyzoites and bradyzoites\",\n      \"pmids\": [\"8344403\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Sorting mechanism directing GRA1 to matrix vs. membrane unknown\", \"No functional test of matrix localization\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Reciprocal immunolabeling and fractionation distinguished GRA1's peripheral IVN association from GRA2's integral membrane insertion, defining how GRA1 engages the intravacuolar network.\",\n      \"evidence\": \"IFA, immunoEM, and cell fractionation of infected host cells comparing GRA1 and GRA2\",\n      \"pmids\": [\"7615684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of GRA1 peripheral membrane association not defined\", \"No demonstration of direct lipid or protein binding to IVN\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Promoter dissection identified the cis-elements driving GRA1 transcription, defining how its high-level expression is regulated.\",\n      \"evidence\": \"Transient CAT reporter transfection with promoter deletion and mutation analysis\",\n      \"pmids\": [\"8858595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting factors binding the A/TGAGACG motifs not identified\", \"Link to stage-specific expression not established\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Secretion-kinetics and stage-comparison studies established that GRA1 discharge is temporally distinct (post-invasion) and stage-regulated, being retained in sporozoites rather than secreted into the first PV.\",\n      \"evidence\": \"Quantitative immunoassay/IFA/IEM of invasion kinetics; immunolabeling of sporozoite versus tachyzoite invasion\",\n      \"pmids\": [\"9208224\", \"9353039\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signal triggering delayed dense-granule secretion unknown\", \"Mechanism of sporozoite-specific retention unresolved\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"In vivo staining across enteric stages showed GRA1 is absent from merozoites and coccidian stages, refining the stage-specificity of its expression.\",\n      \"evidence\": \"Immunolight and electron microscopy of cat intestinal sections\",\n      \"pmids\": [\"10072322\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Basis of stage-specific transcriptional silencing not defined\", \"Independence from NTPase not mechanistically explained\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Analysis of MIC5-knockout parasites revealed that GRA1 undergoes regulated proteolytic processing controlled by the MIC5/MPP2 axis, connecting dense-granule and micronemal protein maturation.\",\n      \"evidence\": \"MIC5 KO with genetic complementation, GRA1 Western blot, and ALLN protease inhibition\",\n      \"pmids\": [\"16980407\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct protease acting on GRA1 not identified\", \"Functional consequence of GRA1 processing unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Co-localization studies placed GRA1 within early post-invasion host-cytosolic strands containing GRA3 and GRA7, hinting at coordination between dense-granule and rhoptry protein networks.\",\n      \"evidence\": \"IFA co-localization of GRA7 with GRA1, GRA3, ROP2, ROP4 in infected cells\",\n      \"pmids\": [\"18809661\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-localization by IFA only, no direct interaction shown for GRA1\", \"Functional role of GRA1 in these strands not tested\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"A host-directed assay showed recombinant GRA1 can drive human monocyte apoptosis via autocrine TGF-\\u03b2 signaling, indicating an immunomodulatory activity distinct from its intravacuolar structural role.\",\n      \"evidence\": \"Monocyte apoptosis assays with recombinant GRA1, TGF-\\u03b2 receptor inhibition, and neutralizing antibodies\",\n      \"pmids\": [\"21390541\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of secreted native GRA1 in this pathway unclear\", \"GRA1 receptor/target on monocytes not identified\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Systematic knockout attempts across the GRA1\\u20139 loci found GRA1 refractory to deletion in the RH strain, implicating it as essential in contrast to the dispensable GRA2\\u20139.\",\n      \"evidence\": \"Homologous-recombination gene targeting in T. gondii RH strain\",\n      \"pmids\": [\"27458822\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative result does not formally prove essentiality\", \"No conditional system used to define the essential function here\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Proximity-labeling mapping used GRA1 as a bait to enumerate the PV proteome, defining its molecular neighborhood and identifying novel dense granule proteins.\",\n      \"evidence\": \"BioID (GRA1-BirA*) and APEX (GRA1-APEX) proximity labeling with mass spectrometry and IFA validation\",\n      \"pmids\": [\"30362762\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Proximity does not establish direct GRA1 binding\", \"Which neighbors are functional partners not determined\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Time-resolved imaging during in vitro cyst formation showed GRA1 dynamically relocalizes to build a continuous cyst-interior matrix and inner cyst wall, extending its structural role into the bradyzoite stage.\",\n      \"evidence\": \"IFA of GRA1 with cyst-wall markers over differentiation time course; genetic deletion of other GRAs\",\n      \"pmids\": [\"31619500\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GRA1 KO not achievable, so its functional requirement for cyst matrix untested\", \"Signals directing GRA1 relocalization unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Conditional depletion finally resolved GRA1's essential mechanism, showing it maintains IVN integrity required for GRA effector secretion, host-nutrient scavenging, metabolic homeostasis, and organelle integrity.\",\n      \"evidence\": \"Conditional degron depletion of GRA1 with metabolomics, organelle imaging, GRA localization, nutrient uptake, and differentiation assays\",\n      \"pmids\": [\"40576341\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular basis of GRA1-IVN membrane interaction not defined\", \"Whether metabolic defects are all downstream of IVN disruption vs. independent roles not separated\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Detection of GRA1 in infected-neuron extracellular vesicles that reprogram astrocytes raised the possibility of a GRA1 role in host CNS signaling beyond the PV.\",\n      \"evidence\": \"EV proteomics, TEM/NTA, and astrocyte gene-expression assays from infected primary neurons\",\n      \"pmids\": [\"40523037\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GRA1's individual contribution to EV-driven astrocyte effects not dissected\", \"Mechanism of GRA1 loading into EVs unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct molecular basis of GRA1's peripheral association with IVN membranes and how its calcium-binding activity contributes to IVN integrity and nutrient scavenging remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of GRA1 or its membrane/Ca2+-binding interface\", \"Whether Ca2+ binding is required for IVN function untested\", \"Direct binding partners on the IVN not identified\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005509\", \"supporting_discovery_ids\": [1, 15], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0019898\", \"supporting_discovery_ids\": [2, 14], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020003\", \"supporting_discovery_ids\": [0, 2, 4], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0020026\", \"supporting_discovery_ids\": [0, 1, 4], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0044222\", \"supporting_discovery_ids\": [2, 14], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:1903561\", \"supporting_discovery_ids\": [16], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0015850\", \"supporting_discovery_ids\": [14], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0006006\", \"supporting_discovery_ids\": [14], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0043065\", \"supporting_discovery_ids\": [11], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GRA2 (distinct IVN association; co-localized) [#2]\",\n      \"GRA3, GRA7 (post-invasion host-cytosolic strands, co-localization) [#7]\",\n      \"GRA17 and other GRA effectors (secretion dependent on GRA1) [#14]\",\n      \"MIC5/MPP2 (regulates GRA1 proteolytic processing) [#12]\",\n      \"46 PV proteins identified by GRA1 proximity labeling, incl. 20 known GRAs [#10]\"\n    ],\n    \"other_free_text\": [\n      \"GRA1 transcription requires repeated A/TGAGACG cis-elements at -129 to -47 of its promoter [#3]\",\n      \"Stage-specific expression/secretion: secreted in tachyzoites and bradyzoites, retained intracellularly in sporozoites, absent from merozoites/enteric stages [#5, #6]\",\n      \"During cyst formation GRA1 relocalizes to the cyst-interior matrix and inner cyst wall [#9]\",\n      \"Deletion of GRA1 not achievable in RH strain, consistent with essentiality [#8]\",\n      \"Recombinant GRA1 does not stimulate IFN-\\u03b3 production by microglia [#13]\",\n      \"ER-targeted GRA1 in macrophages delays arachidonic-acid-stimulated Ca2+ peaks, consistent with Ca2+-buffering (Low confidence, heterologous) [#15]\"\n    ]\n  },\n  \"strain_conflicts\": []\n}","audit_flag":null,"strains":[{"strain":"ME49","gene_id":"TGME49_270250","name":"GRA1","product":"dense granule protein GRA1","uniprot_acc":"S8GIU2","chromosome":"TGME49_chrVIII","start_pos":5309215},{"strain":"GT1","gene_id":"TGGT1_270250","name":null,"product":"dense granule protein GRA1","uniprot_acc":null,"chromosome":"TGGT1_chrVIII","start_pos":5308049},{"strain":"RH88","gene_id":"TGRH88_081130","name":null,"product":"dense granule protein GRA1","uniprot_acc":null,"chromosome":"CM023089","start_pos":10428679},{"strain":"VEG","gene_id":"TGVEG_270250","name":null,"product":"dense granule protein GRA1","uniprot_acc":"B9Q5Z2","chromosome":"TGVEG_chrVIII","start_pos":5323347}]}